Relmada Therapeutics, Inc. (RLMD)
NASDAQ: RLMD · Real-Time Price · USD
3.640
+0.010 (0.28%)
Oct 22, 2024, 4:00 PM EDT - Market closed
Relmada Therapeutics Market Cap
Relmada Therapeutics has a market cap or net worth of $109.83 million as of October 23, 2024. Its market cap has increased by 16.97% in one year.
Market Cap
109.83M
Enterprise Value
39.40M
1-Year Change
16.97%
Ranking
Category
Stock Price
$3.64
Market Cap Chart
Since September 30, 2015, Relmada Therapeutics's market cap has increased from $56.60M to $109.83M, an increase of 94.05%. That is a compound annual growth rate of 7.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2024 | 109.80M | -11.88% |
| Dec 29, 2023 | 124.60M | 18.67% |
| Dec 30, 2022 | 105.00M | -73.42% |
| Dec 31, 2021 | 395.00M | -24.17% |
| Dec 31, 2020 | 520.90M | 30.00% |
| Dec 31, 2019 | 400.70M | 1,125.38% |
| Dec 31, 2018 | 32.70M | 247.87% |
| Dec 29, 2017 | 9.40M | -28.24% |
| Dec 30, 2016 | 13.10M | -54.67% |
| Dec 31, 2015 | 28.90M | -48.94% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| KORU Medical Systems | 112.80M |
| Myomo | 112.74M |
| Avalo Therapeutics | 112.12M |
| Elutia | 111.38M |
| OptimizeRx | 110.11M |
| Sensus Healthcare | 109.81M |
| Rockwell Medical | 107.36M |
| Assertio Holdings | 106.78M |